Echoes of the embryo: Using the developmental biology toolkit to study cancer

DMM Disease Models and Mechanisms

Volumn 9, Issue 2, 2016, Pages 105-114

  Aiello, Nicole M ^a   Stanger, Ben Z ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cancer; Embryology; Intravital imaging; Lineage tracing; Reprogramming

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; TUMOR MARKER;

CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CARCINOGENESIS; CELL HETEROGENEITY; CELL INTERACTION; CELL MOTION; CHILDHOOD CANCER; DRUG RESPONSE; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MOLECULAR PATHOLOGY; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; REVIEW; TUMOR INVASION; GENETICS; MUTATION; NEOPLASMS; PATHOLOGY;

ANTINEOPLASTIC AGENTS; BIOMARKERS, TUMOR; CARCINOGENESIS; EMBRYONIC DEVELOPMENT; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MUTATION; NEOPLASMS;

EID: 84957943885     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.023184     Document Type: Review

References (116)

1. Alcantara Llaguno, S., Chen, J., Kwon, C.-H., Jackson, E. L., Li, Y., Burns, D. K., Alvarez-Buylla, A. and Parada, L. F. (2015). Malignant Astrocytomas Originate from Neural Stem/Progenitor Cells in a Somatic Tumor Suppressor Mouse Model. Cancer Cell 28, 429-440.
2. Anastas, J. N. and Moon, R. T. (2013). WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer 13, 11-26.
3. Andersson, E. R., Sandberg, R. and Lendahl, U. (2011). Notch signaling: Simplicity in design, versatility in function. Development 138, 3593-3612.
4. Apostolou, E. and Hochedlinger, K. (2013). Chromatin dynamics during cellular reprogramming. Nature 502, 462-471.
5. Araki, K., Imaizumi, T., Okuyama, K., Oike, Y. and Yamamura, K.-I. (1997). Efficiency of recombination by Cre transient expression in embryonic stem cells: Comparison of various promoters. J. Biochem. 122, 977-982.
6. Athar, M., Tang, X., Lee, J. L., Kopelovich, L. and Kim, A. L. (2006). Hedgehog signalling in skin development and cancer. Exp. Dermatol. 15, 667-677.
7. Avila, J. L. and Kissil, J. L. (2013). Notch signaling in pancreatic cancer: Oncogene or tumor suppressor? Trends Mol. Med. 19, 320-327.
8. Aytes, A.,Mitrofanova,A., Kinkade, C.W.,Lefebvre, C.,Lei,M.,Phelan,V.,LeKaye, H. C., Koutcher, J. A., Cardiff, R. D., Califano, A. et al. (2013). ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer. Proc. Natl. Acad. Sci. USA 110, E3506-E3515.
9. Bailey, J. M., Swanson, B. J., Hamada, T., Eggers, J. P., Singh, P. K., Caffery, T., Ouellette, M. M. and Hollingsworth, M. A. (2008). Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin. Cancer Res. 14, 5995-6004.
10. Bailey, J. M., Mohr, A. M. and Hollingsworth, M. A. (2009). Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene 28, 3513-3525.
11. Barker, N., Van Es, J. H., Kuipers, J., Kujala, P., Van Den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P. J. et al. (2007). Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-1007.
12. Barker, N.,Ridgway,R.A., Van Es, J. H., Van deWetering,M., Begthel, H., Van Den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J. and Clevers, H. (2009). Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608-611.
13. Bell, D. A. (2005). Origins and molecular pathology of ovarian cancer. Mod. Pathol. 18, S19-S32.
14. Birgbauer, E., Sechrist, J., Bronnerfraser, M. and Fraser, S. (1995). Rhombomeric origin and rostrocaudal reassortment of neural crest cells revealed by intravital microscopy. Development 121, 935-945.
15. Bolo?s, V., Grego-Bessa, J. and De La Pompa, J. L. (2007). Notch signaling in development and cancer. Endocr. Rev. 28, 339-363.
16. Bray, S. J. (2006). Notch signalling: A simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7, 678-689.
17. Briscoe, J. and The?rond, P. P. (2013). The mechanisms of Hedgehog signalling and its roles in development and disease. Nat. Rev. Mol. Cell Biol. 14, 416-429.
18. Butterfield, N. C., McGlinn, E. andWicking, C. (2010). The molecular regulation of vertebrate limb patterning. Curr. Top. Dev. Biol. 90, 319-341.
19. Campagnola, P. (2011). Second harmonic generation imaging microscopy: Applications to diseases diagnostics. Anal. Chem. 83, 3224-3231.
20. Carette, J. E., Pruszak, J., Varadarajan, M., Blomen, V. A., Gokhale, S., Camargo, F. D., Wernig, M., Jaenisch, R. and Brummelkamp, T. R. (2010). Generation of iPSCs from cultured human malignant cells. Blood 115, 4039-4042.
21. Castellana, D., Paus, R. and Perez-Moreno, M. (2014). Macrophages contribute to the cyclic activation of adult hair follicle stem cells. PLoS Biol. 12, e1002002.
22. Chen, J., Li, Y., Yu, T.-S., McKay, R. M., Burns, D. K., Kernie, S. G. and Parada, L. F. (2012). A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488, 522-526.
23. Cheung, M., Chaboissier, M.-C., Mynett, A., Hirst, E., Schedl, A. and Briscoe, J. (2005). The transcriptional control of trunk neural crest induction, survival, and delamination. Dev. Cell 8, 179-192.
24. Choi, N., Zhang, B., Zhang, L., Ittmann, M. and Xin, L. (2012). Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell 21, 253-265.
25. Ciruna, B. and Rossant, J. (2001). FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev. Cell 1, 37-49.
26. Comijn, J., Berx, G., Vermassen, P., Verschueren, K., Van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D. and Van Roy, F. (2001). The twohanded E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 7, 1267-1278.
27. Dale, L. and Slack, J. M. W. (1987). Fate map for the 32-cell stage of Xenopus- Laevis. Development 99, 527-551.
28. Dawson, M. A. and Kouzarides, T. (2012). Cancer epigenetics: Frommechanism to therapy. Cell 150, 12-27.
29. De Calisto, J., Araya, C., Marchant, L., Riaz, C. F. and Mayor, R. (2005). Essential role of non-canonical Wnt signalling in neural crest migration. Development 132, 2587-2597.
30. De Craene, B., Gilbert, B., Stove, C., Bruyneel, E., Van Roy, F. and Berx, G. (2005). The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res. 65, 6237-6244.
31. Demehri, S. and Kopan, R. (2009). Notch signaling in bulge stem cells is not required for selection of hair follicle fate. Development 136, 891-896.
32. Dieguez-Hurtado, R., Martín, J., Martínez-Corral, I., Martínez, M. D., Megas, D., Olmeda, D. and Ortega, S. (2011). A Cre-reporter transgenic mouse expressing the Far-red fluorescent protein katushka. Genesis 49, 36-45.
33. Dorsky, R. I., Yang-Snyder, J., Moon, R. T. and Raible, D. W. (1998). Control of neural crest cell fate by the Wnt signaling pathway. Dev. Biol. 198, 179-179.
34. Driessens, G., Beck, B., Caauwe, A., Simons, B. D. and Blanpain, C. (2012). Defining the mode of tumour growth by clonal analysis. Nature 488, 527-530.
35. Feil, R., Brocard, J., Mascrez, B., LeMeur, M., Metzger, D. and Chambon, P. (1996). Ligand-activated site-specific recombination in mice. Proc. Natl. Acad. Sci. USA 93, 10887-10890.
36. Fein, M. R. and Egeblad, M. (2013). Caught in the act: Revealing the metastatic process by live imaging. Dis. Model. Mech. 6, 580-593.
37. Fu, J. and Hsu, W. (2013). Epidermal Wnt controls hair follicle induction by orchestrating dynamic signaling crosstalk between the epidermis and dermis. J. Invest. Dermatol. 133, 890-898.
38. Funato, K., Major, T., Lewis, P.W., Allis, C. D. and Tabar, V. (2014). Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation. Science 346, 1529-1533.
39. Giles, R. H., Van Es, J. H. and Clevers, H. (2003). Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653, 1-24.
40. Greaves, M. (2015). Evolutionary determinants of cancer. Cancer Discov. 5, 806-820.
41. Grove, C. S. and Vassilou, G. S (2014). Acute myeloid leukaemia: A paradigm for the clonal evolution of cancer? Dis. Model. Mech. 7, 941-951.
42. Guest, R. V., Boulter, L., Kendall, T. J., Minnis-Lyons, S. E., Walker, R., Wigmore, S. J., Sansom, O. J. and Forbes, S. J. (2014). Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma. Cancer Res. 74, 1005-1010.
43. Gupta, G. P. and Massague?, J. (2006). Cancer metastasis: Building a framework. Cell 127, 679-695.
44. Hajra, K. M., Chen, D. Y. S. and Fearon, E. R. (2002). The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 62, 1613-1618.
45. Hamilton, D. L. and Abremski, K. (1984). Site-specific recombination by the bacteriophage-P1 lox-Cre system - Cre-mediated synapsis of 2lox sites. J. Mol. Biol. 178, 481-486.
46. Heisenberg, C.-P. and Solnica-Krezel, L. (2008). Back and forth between cell fate specification and movement during vertebrate gastrulation. Curr. Opin. Genet. Dev. 18, 311-316.
47. Henner, A., Ventura, P. B., Jiang, Y. and Zong, H. (2013). MADM-ML, a mouse genetic mosaic system with increased clonal efficiency. PLoS ONE 8, e77672.
48. Hrycaj, S. M., Dye, B. R., Baker, N. C., Larsen, B. M., Burke, A. C., Spence, J. R. andWellik, D. M. (2015). Hox5 genes regulate the Wnt2/2b-Bmp4-signaling axis during lung development. Cell Rep. 12, 903-912.
49. Ingham, P. W. and McMahon, A. P. (2001). Hedgehog signaling in animal development: Paradigms and principles. Genes Dev. 15, 3059-3087.
50. Isern, J., Garcia-Garcia, A., Martin, A. M., Arranz, L., Martin-Perez, D., Torroja, C., Sanchez-Cabo, F. and Mendez-Ferrer, S. (2014). The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem-cell-niche function. Elife doi:10.7554/eLife.03696.
51. Jacobetz, M. A., Chan, D. S., Neesse, A., Bapiro, T. E., Cook, N., Frese, K. K., Feig, C., Nakagawa, T., Caldwell, M. E., Zecchini, H. I. et al. (2013). Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut 62, 112-120.
52. Kienast, Y., von Baumgarten, L., Fuhrmann, M., Klinkert,W. E. F., Goldbrunner, R., Herms, J. and Winkler, F. (2010). Real-time imaging reveals the single steps of brain metastasis formation. Nat. Med. 16, 116-122.
53. Kim, K., Doi, A.,Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M. J., Ji, H., Ehrlich, L. I. R. et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290.
54. Kim, J., Hoffman, J. P., Alpaugh, R. K., Rhim, A. D., Reichert, M., Stanger, B., Furth, E. E., Sepulveda, A. R., Yuan, C.-X.,Won, K.-J. et al. (2013). An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression. Cell Rep. 3, 2088-2099.
55. Kimmel, C. B.,Warga, R. M. and Schilling, T. F. (1990). Origin and organization of the zebrafish fate map. Development 108, 581-594.
56. Kotini, A. G., Chang, C.-J., Boussaad, I., Delrow, J. J., Dolezal, E. K., Nagulapally, A. B., Perna, F., Fishbein, G. A., Klimek, V. M., Hawkins, R. D. et al. (2015). Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells. Nat. Biotechnol. 33, 646-655.
57. Kumano, K., Arai, S., Hosoi, M., Taoka, K., Takayama, N., Otsu, M., Nagae, G., Ueda, K., Nakazaki, K., Kamikubo, Y. et al. (2012). Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples. Blood 119, 6234-6242.
58. Landsman, L., Nijagal, A., Whitchurch, T. J., VanderLaan, R. L., Zimmer, W. E., MacKenzie, T. C. and Hebrok, M. (2011). Pancreatic mesenchyme regulates epithelial organogenesis throughout development. PLoS Biol. 9, e1001143.
59. Lawson, N. D. andWeinstein, B. M. (2002). In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 248, 307-318.
60. Lee, D.-F., Su, J., Kim, H. S., Chang, B., Papatsenko, D., Zhao, R., Yuan, Y., Gingold, J., Xia, W., Darr, H. et al. (2015). Modeling familial cancer with induced pluripotent stem cells. Cell 161, 240-254.
61. Levinson, R. and Mendelsohn, C. (2003). Stromal progenitors are important for patterning epithelial and mesenchymal cell types in the embryonic kidney. Semin. Cell Dev. Biol. 14, 225-231.
62. Li, S. L., Park, H., Trempus, C. S., Gordon, D., Liu, Y. P., Cotsarelis, G. and Morris, R. J. (2013). A Keratin 15 containing stem cell population from the hair follicle contributes to squamous papilloma development in the mouse. Mol. Carcinogen. 52, 751-759.
63. Li, J., Feng, J., Liu, Y., Ho, T.-V., Grimes, W., Ho, H. A., Park, S., Wang, S. and Chai, Y. (2015). BMP-SHH signaling network controls epithelial stem cell fate via regulation of its niche in the developing tooth. Dev. Cell 33, 125-135.
64. Liu, C., Sage, J. C., Miller, M. R., Verhaak, R. G. W., Hippenmeyer, S., Vogel, H., Foreman, O., Bronson, R. T., Nishiyama, A., Luo, L. Q. et al. (2011). Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 146, 209-221.
65. Loebel, D. A. F.,Watson, C. M., De Young, R. A. and Tam, P. P. L. (2003). Lineage choice and differentiation in mouse embryos and embryonic stem cells. Dev. Biol. 264, 1-14.
66. Looney, M. R., Thornton, E. E., Sen, D., Lamm, W. J., Glenny, R. W. and Krummel, M. F. (2011). Stabilized imaging of immune surveillance in the mouse lung. Nat. Methods 8, 91-96.
67. Lo?pez-Iglesias, P., Alcaina, Y., Tapia, N., Sabour, D., Arauzo-Bravo, M. J., De La Maza, D. S., Berra, E.,O'Mara, A. N., Nistal, M., Ortega, S. et al. (2015). Hypoxia induces pluripotency in primordial germ cells by HIF1alpha stabilization and Oct4 deregulation. Antioxid. Redox Signal. 22, 205-223.
68. Maddipati, R. and Stanger, B. (2015). Pancreatic Cancer Metastases Harbor Evidence of Polyclonality. Cancer Discov. 5, 1086-1097.
69. Marusyk, A., Tabassum, D. P., Altrock, P. M., Almendro, V., Michor, F. and Polyak, K. (2014). Non-cell-autonomous driving of tumour growth supports subclonal heterogeneity. Nature 514, 54-58.
70. Massarwa, R. and Niswander, L. (2013). In toto live imaging of mouse morphogenesis and new insights into neural tube closure. Development 140, 226-236.
71. Matsushita, S. (1996). Fate mapping study of the endoderm of the 1.5-day-old chick embryo. Roux's Arch. Dev. Biol. 205, 225-231.
72. Miyoshi, N., Ishii, H., Nagai, K.-I., Hoshino, H., Mimori, K., Tanaka, F., Nagano, H., Sekimoto, M., Doki, Y. and Mori, M. (2010). Defined factors induce reprogramming of gastrointestinal cancer cells. Proc. Natl. Acad. Sci. USA 107, 40-45.
73. Moustakas, A. and Heldin, C.-H. (2007). Signaling networks guiding epithelialmesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 98, 1512-1520.
74. Nagy, A. (2000). Cre recombinase: The universal reagent for genome tailoring. Genesis 26, 99-109.
75. Nakasone, E. S., Askautrud, H. A., Kees, T., Park, J.-H., Plaks, V., Ewald, A. J., Fein, M., Rasch, M. G., Tan, Y.-X., Qiu, J. et al. (2012). Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell 21, 488-503.
76. Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D. et al. (2009). Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457-1461.
77. O? zdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V. et al. (2014). Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 25, 719-734.
78. Pan, D. (2010). The Hippo signaling pathway in development and cancer. Dev. Cell 19, 491-505.
79. Papp, B. and Plath, K. (2013). Epigenetics of reprogramming to induced pluripotency. Cell 152, 1324-1343.
80. Peinado, H., Olmeda, D. and Cano, A. (2007). Snail, ZEB and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat. Rev. Cancer 7, 415-428.
81. Petersen, C. P. and Reddien, P. W. (2009). Wnt signaling and the polarity of the primary body axis. Cell 139, 1056-1068.
82. Polakis, P. (2007). The many ways of Wnt in cancer. Curr. Opin. Genet. Dev. 17, 45-51.
83. Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D. and Hingorani, S. R. (2012). Enzymatic targeting of the Stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 21, 418-429.
84. Radtke, F. and Raj, K. (2003). The role of Notch in tumorigenesis: Oncogene or tumour suppressor? Nat. Rev. Cancer 3, 756-767.
85. Ramos-Mejia, V., Fraga, M. F. and Menendez, P. (2012). iPSCs from cancer cells: Challenges and opportunities. Trends Mol. Med. 18, 245-247.
86. Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H. et al. (2012). EMT and dissemination precede pancreatic tumor formation. Cell 148, 349-361.
87. Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersa, I. W. et al. (2014). Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25, 735-747.
88. Ricard, C., Stanchi, F., Rougon, G. and Debarbieux, F. (2014). An orthotopic glioblastoma mouse model maintaining brain parenchymal physical constraints and suitable for intravital two-photon microscopy. J. Vis. Exp. doi:10.3791/51108.
89. Ritsma, L., Steller, E. J. A., Beerling, E., Loomans, C. J. M., Zomer, A., Gerlach, C., Vrisekoop, N., Seinstra, D., Van Gurp, L., Schafer, R. et al. (2012). Intravital microscopy through an abdominal imaging window reveals a pre-micrometastasis stage during liver metastasis. Sci. Transl. Med. 4, 158ra145.
90. Sauer, B. and Henderson, N. (1988). Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. USA 85, 5166-5170.
91. Schepers, A. G., Snippert, H. J., Stange, D. E., Van Den Born, M., Van Es, J. H., Van De Wetering, M. and Clevers, H. (2012). Lineage tracing reveals Lgr5(+) stem cell activity in mouse intestinal adenomas. Science 337, 730-735.
92. Schroeder, K. M., Hoeman, C. M. and Becher, O. J. (2014). Children are not just little adults: Recent advances in understanding of diffuse intrinsic pontine glioma biology. Pediatr. Res. 75, 205-209.
93. Slack, J. M. W. (2006). Essential Developmental Biology. Malden, MA, USA: Blackwell Publishing Ltd.
94. Snippert, H. J., Van Der Flier, L. G., Sato, T., Van Es, J. H., Van Den Born, M., Kroon-Veenboer, C., Barker, N., Klein, A. M., Van Rheenen, J., Simons, B. D. et al. (2010). Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143, 134-144.
95. Sokol, S. Y. (2011). Maintaining embryonic stem cell pluripotency with Wnt signaling. Development 138, 4341-4350.
96. Sternberg, N., Hamilton, D. and Hoess, R. (1981). Bacteriophage-P1 site-specific recombination .2. recombination between loxp and the bacterial chromosome. J. Mol. Biol. 150, 487-507.
97. Stricker, S. H., Feber, A., Engstrom, P. G., Caren, H., Kurian, K. M., Takashima, Y., Watts, C., Way, M., Dirks, P., Bertone, P. et al. (2013). Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner. Genes Dev. 27, 654-669.
98. Strutz, F., Zeisberg, M., Ziyadeh, F. N., Yang, C.-Q., Kalluri, R., Muller, G. A. and Neilson, E. G. (2002). Role of basic fibroblast growth factor-2 in epithelialmesenchymal transformation. Kidney Int. 61, 1714-1728.
99. Tabassum, D. P. and Polyak, K. (2015). Tumorigenesis: It takes a village. Nat. Rev. Cancer 15, 473-483.
100. Takahashi, K. and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
101. Thesleff, I. and Sharpe, P. (1997). Signalling networks regulating dental development. Mech. Dev. 67, 111-123.
102. Tian, H., Callahan, C. A., DuPree, K. J., Darbonne,W. C., Ahn, C. P., Scales, S. J. and De Sauvage, F. J. (2009). Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc. Natl. Acad. Sci. USA 106, 4254-4259.
103. Trakala, M., Rodrguez-Acebes, S., Maroto, M., Symonds, C. E., Santamara, D., Ortega, S., Barbacid, M., Me?ndez, J. and Malumbres, M. (2015). Functional reprogramming of polyploidization in megakaryocytes. Dev. Cell 32, 155-167.
104. Ulloa, F. and Briscoe, J. (2007). Morphogens and the control of cell proliferation and patterning in the spinal cord. Cell Cycle 6, 2640-2649.
105. Ustione, A. and Piston, D. W. (2011). A simple introduction to multiphoton microscopy. J. Microsc. 243, 221-226.
106. Utikal, J., Maherali, N., Kulalert, W. and Hochedlinger, K. (2009). Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J. Cell Sci. 122, 3502-3510.
107. Vanner, R. J., Remke, M., Gallo, M., Selvadurai, H. J., Coutinho, F., Lee, L., Kushida, M., Head, R., Morrissy, S., Zhu, X. et al. (2014). Quiescent Sox(2+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma. Cancer Cell 26, 33-47.
108. Voziyanov, Y., Pathania, S. and Jayaram, M. (1999). A general model for sitespecific recombination by the integrase family recombinases. Nucleic Acids Res. 27, 930-941.
109. Wang, G. Y., Wang, J., Mancianti, M.-L. and Epstein, E. H. (2011). Basal cell carcinomas arise from hair follicle stem cells in Ptch1(+/?) mice. Cancer Cell 19, 114-124.
110. Wells, K. L., Gaete, M., Matalova, E., Deutsch, D., Rice, D. and Tucker, A. S. (2013). Dynamic relationship of the epithelium and mesenchyme during salivary gland initiation: The role of Fgf10. Biol. Open 2, 981-989.
111. Wyckoff, J. B., Wang, Y., Lin, E. Y., Li, J.-F., Goswami, S., Stanley, E. R., Segall, J. E., Pollard, J. W. and Condeelis, J. (2007). Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 67, 2649-2656.
112. Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A. andWeinberg, R. A. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939.
113. Zeller, R., Lo?pez-Ros, J. and Zuniga, A. (2009). Vertebrate limb bud development: Moving towards integrative analysis of organogenesis. Nat. Rev. Genet. 10, 845-858.
114. Zhang, X., Cruz, F. D., Terry, M., Remotti, F. and Matushansky, I. (2013). Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming. Oncogene 32, 2249-2260.
115. Zomer, A., Maynard, C., Verweij, F. J., Kamermans, A., Scha? fer, R., Beerling, E., Schiffelers, R. M., deWit, E., Berenguer, J., Ellenbroek, S. I. J. et al. (2015). In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell 161, 1046-1057.
116. Zong, H., Espinosa, J. S., Su, H. H., Muzumdar, M. D. and Luo, L. (2005). Mosaic analysis with double markers in mice. Cell 121, 479-492.